Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleAccepted Article

Association between Comorbidities and Quality of Life in Psoriatic Arthritis: Results from a Multicentric Cross-sectional Study (PSAQUAL study)

Bavière W¹, Deprez X², Houvenagel E³, Philippe P¹, Deken V⁴, Flipo RM¹ and Paccou J¹
The Journal of Rheumatology June 2019, jrheum.181471; DOI: https://doi.org/10.3899/jrheum.181471
Bavière W¹
From Service de rhumatologie, CHU, 59000 Lille, France; Service de rhumatologie, CH Valenciennes, 59300 Valenciennes, France; Service de rhumatologie, Hôpital Saint-Philibert, 59160 Lomme, France; Département de Biostatistiques, EA 2694 - Santé publique : épidémiologie et qualité des soins, Université de Lille, CHU Lille, Lille, France. The study protocol was approved by the local Institutional Review Board (reference 2018- A00449-46), and the study procedures complied with the ethical standards of the relevant institutional and national Human Experimentation Ethics Committees (reference CPP 3590- NI), and the Helsinki Declaration of 1975, as revised in 2000. All patients provided written informed consent. Corresponding author: Julien Paccou, MD, PhD Service de rhumatologie, Hôpital Roger Salengro, Rue Emile Laine, CHU, 59037 Lille cedex, France. Email: julien.paccou@chru-lille.fr
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deprez X²
From Service de rhumatologie, CHU, 59000 Lille, France; Service de rhumatologie, CH Valenciennes, 59300 Valenciennes, France; Service de rhumatologie, Hôpital Saint-Philibert, 59160 Lomme, France; Département de Biostatistiques, EA 2694 - Santé publique : épidémiologie et qualité des soins, Université de Lille, CHU Lille, Lille, France. The study protocol was approved by the local Institutional Review Board (reference 2018- A00449-46), and the study procedures complied with the ethical standards of the relevant institutional and national Human Experimentation Ethics Committees (reference CPP 3590- NI), and the Helsinki Declaration of 1975, as revised in 2000. All patients provided written informed consent. Corresponding author: Julien Paccou, MD, PhD Service de rhumatologie, Hôpital Roger Salengro, Rue Emile Laine, CHU, 59037 Lille cedex, France. Email: julien.paccou@chru-lille.fr
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Houvenagel E³
From Service de rhumatologie, CHU, 59000 Lille, France; Service de rhumatologie, CH Valenciennes, 59300 Valenciennes, France; Service de rhumatologie, Hôpital Saint-Philibert, 59160 Lomme, France; Département de Biostatistiques, EA 2694 - Santé publique : épidémiologie et qualité des soins, Université de Lille, CHU Lille, Lille, France. The study protocol was approved by the local Institutional Review Board (reference 2018- A00449-46), and the study procedures complied with the ethical standards of the relevant institutional and national Human Experimentation Ethics Committees (reference CPP 3590- NI), and the Helsinki Declaration of 1975, as revised in 2000. All patients provided written informed consent. Corresponding author: Julien Paccou, MD, PhD Service de rhumatologie, Hôpital Roger Salengro, Rue Emile Laine, CHU, 59037 Lille cedex, France. Email: julien.paccou@chru-lille.fr
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philippe P¹
From Service de rhumatologie, CHU, 59000 Lille, France; Service de rhumatologie, CH Valenciennes, 59300 Valenciennes, France; Service de rhumatologie, Hôpital Saint-Philibert, 59160 Lomme, France; Département de Biostatistiques, EA 2694 - Santé publique : épidémiologie et qualité des soins, Université de Lille, CHU Lille, Lille, France. The study protocol was approved by the local Institutional Review Board (reference 2018- A00449-46), and the study procedures complied with the ethical standards of the relevant institutional and national Human Experimentation Ethics Committees (reference CPP 3590- NI), and the Helsinki Declaration of 1975, as revised in 2000. All patients provided written informed consent. Corresponding author: Julien Paccou, MD, PhD Service de rhumatologie, Hôpital Roger Salengro, Rue Emile Laine, CHU, 59037 Lille cedex, France. Email: julien.paccou@chru-lille.fr
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deken V⁴
From Service de rhumatologie, CHU, 59000 Lille, France; Service de rhumatologie, CH Valenciennes, 59300 Valenciennes, France; Service de rhumatologie, Hôpital Saint-Philibert, 59160 Lomme, France; Département de Biostatistiques, EA 2694 - Santé publique : épidémiologie et qualité des soins, Université de Lille, CHU Lille, Lille, France. The study protocol was approved by the local Institutional Review Board (reference 2018- A00449-46), and the study procedures complied with the ethical standards of the relevant institutional and national Human Experimentation Ethics Committees (reference CPP 3590- NI), and the Helsinki Declaration of 1975, as revised in 2000. All patients provided written informed consent. Corresponding author: Julien Paccou, MD, PhD Service de rhumatologie, Hôpital Roger Salengro, Rue Emile Laine, CHU, 59037 Lille cedex, France. Email: julien.paccou@chru-lille.fr
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Flipo RM¹
From Service de rhumatologie, CHU, 59000 Lille, France; Service de rhumatologie, CH Valenciennes, 59300 Valenciennes, France; Service de rhumatologie, Hôpital Saint-Philibert, 59160 Lomme, France; Département de Biostatistiques, EA 2694 - Santé publique : épidémiologie et qualité des soins, Université de Lille, CHU Lille, Lille, France. The study protocol was approved by the local Institutional Review Board (reference 2018- A00449-46), and the study procedures complied with the ethical standards of the relevant institutional and national Human Experimentation Ethics Committees (reference CPP 3590- NI), and the Helsinki Declaration of 1975, as revised in 2000. All patients provided written informed consent. Corresponding author: Julien Paccou, MD, PhD Service de rhumatologie, Hôpital Roger Salengro, Rue Emile Laine, CHU, 59037 Lille cedex, France. Email: julien.paccou@chru-lille.fr
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paccou J¹
From Service de rhumatologie, CHU, 59000 Lille, France; Service de rhumatologie, CH Valenciennes, 59300 Valenciennes, France; Service de rhumatologie, Hôpital Saint-Philibert, 59160 Lomme, France; Département de Biostatistiques, EA 2694 - Santé publique : épidémiologie et qualité des soins, Université de Lille, CHU Lille, Lille, France. The study protocol was approved by the local Institutional Review Board (reference 2018- A00449-46), and the study procedures complied with the ethical standards of the relevant institutional and national Human Experimentation Ethics Committees (reference CPP 3590- NI), and the Helsinki Declaration of 1975, as revised in 2000. All patients provided written informed consent. Corresponding author: Julien Paccou, MD, PhD Service de rhumatologie, Hôpital Roger Salengro, Rue Emile Laine, CHU, 59037 Lille cedex, France. Email: julien.paccou@chru-lille.fr
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • References
  • Info & Metrics
  • PDF
  • eLetters
Next
Loading

Abstract

Objective In psoriatic arthritis (PsA), comorbidities add to the burden of disease, which may lead to poorer quality of life. The purpose of this study was to evaluate the relationship between comorbidities and quality of life (QoL).

Methods Patients from a multicentric, cross-sectional study on comorbidities in PsA were included in the analysis. Data on comorbidities were collected and were subsequently used to compute the modified Rheumatic Disease Comorbidity Index (mRDCI). The Medical Outcomes Study Short Form-36 (SF-36) physical (PCS) and mental component (MCS) summary scales were used to assess QoL.

Results In total, 124 recruited patients fulfilled the CASPAR criteria: 62.1% were male; mean age and mean disease duration were 52.6 ± 12.6 and 11.3 ± 9.6 respectively. The number of comorbid conditions was 2.0 ± 1.3, with 30.6% of the sample having a current or past history of 3 or more comorbidities. In the multivariate linear regression analysis, only anxiety remained significantly related to mental health (p<0.0001). Anxiety alone accounted for 28.7% of the variance in MCS scores. Moreover, MCS was also significantly associated with the mRDCI score, which explained 4.9% of the variance in MCS (β=-1.56 (0.64), R2=0.049, p=0.0167). In contrast, PCS was not significantly associated either with type or number of comorbidities.

Conclusion In this study, the type of comorbidity appeared to have a greater impact than the number of comorbidities. Indeed, anxiety in PsA was independently associated with QoL and would thus be an important factor to take into account in daily clinical practice.

Next
Back to top

In this issue

The Journal of Rheumatology
Vol. 49, Issue 5
1 May 2022
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Association between Comorbidities and Quality of Life in Psoriatic Arthritis: Results from a Multicentric Cross-sectional Study (PSAQUAL study)
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Accepted manuscript
Association between Comorbidities and Quality of Life in Psoriatic Arthritis: Results from a Multicentric Cross-sectional Study (PSAQUAL study)
Bavière W¹, Deprez X², Houvenagel E³, Philippe P¹, Deken V⁴, Flipo RM¹, Paccou J¹
The Journal of Rheumatology Jun 2019, jrheum.181471; DOI: 10.3899/jrheum.181471

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Accepted manuscript
Association between Comorbidities and Quality of Life in Psoriatic Arthritis: Results from a Multicentric Cross-sectional Study (PSAQUAL study)
Bavière W¹, Deprez X², Houvenagel E³, Philippe P¹, Deken V⁴, Flipo RM¹, Paccou J¹
The Journal of Rheumatology Jun 2019, jrheum.181471; DOI: 10.3899/jrheum.181471
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • References
  • Info & Metrics
  • PDF
  • eLetters

Related Articles

Cited By...

More in this TOC Section

  • Is it time to bring back knee washout?
  • Management of calcinosis cutis in rheumatic diseases
  • Personally-Generated Quality of Life Outcomes in Adults with Juvenile Idiopathic Arthritis
Show more Accepted Article

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire